Beta Bionics (NASDAQ:BBNX – Get Free Report) and Baird Medical Investment (NASDAQ:BDMD – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation and analyst recommendations.
Profitability
This table compares Beta Bionics and Baird Medical Investment’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Beta Bionics | -73.02% | -20.29% | -18.32% |
| Baird Medical Investment | N/A | N/A | N/A |
Analyst Ratings
This is a summary of recent ratings and price targets for Beta Bionics and Baird Medical Investment, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Beta Bionics | 1 | 3 | 6 | 1 | 2.64 |
| Baird Medical Investment | 1 | 0 | 0 | 0 | 1.00 |
Valuation & Earnings
This table compares Beta Bionics and Baird Medical Investment”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Beta Bionics | $100.25 million | 4.81 | -$73.20 million | ($1.95) | -5.57 |
| Baird Medical Investment | N/A | N/A | N/A | N/A | N/A |
Baird Medical Investment has lower revenue, but higher earnings than Beta Bionics.
Institutional and Insider Ownership
19.8% of Baird Medical Investment shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Risk and Volatility
Beta Bionics has a beta of 5.6, suggesting that its share price is 460% more volatile than the S&P 500. Comparatively, Baird Medical Investment has a beta of -1.41, suggesting that its share price is 241% less volatile than the S&P 500.
Summary
Beta Bionics beats Baird Medical Investment on 6 of the 11 factors compared between the two stocks.
About Beta Bionics
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
About Baird Medical Investment
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.
Receive News & Ratings for Beta Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beta Bionics and related companies with MarketBeat.com's FREE daily email newsletter.
